Search

Issue
Title
Authors
Chronic obstructive pulmonary disease and associated illnesses
Chuchalin A.G.
Vasaprostan treatment of fibrosing alveolitis in patients withpulmonary hypertension
Popova E.N., Bolevich S.В., Litvitsky P.E., Arkhipova D.V., Osipenko V.I., Kogan E.A., Kornev В.М., Mukhin N.A.
Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome
Movsisyan G.A., Martynyuk T.V., Mershin K.V., Danilov N.M., Satybaldyeva M.A., Reshetnyak T.M., Akchurin R.S., Nasonov E.L., Chazova I.Y.
Analysis of the management of hypertension complications in patients during emergency care
Alpysova A.R., Subbota Y.V., Adambekova A.K., Telembetov N.T., Maratkyzy M.
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M.
Chronic obstructive pulmonary disease concurrent with hypertension: Evaluation of the therapeutic effect of prolonged-release indapamide
Ovcharenko S.I., Morozova T.E., Nersesyan Z.N.
Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
Volkov A.V., Iudkina N.N., Nikolaeva E.V., Kurmukov I.A., Glukhova S.I., Nasonov E.L.
Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension
Martyniuk T.V., Zykov K.A., Antonova O.I., Rvacheva A.V., Arkhipova O.A., Kobal' E.A., Masenko V.P., Chazova I.E.
Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension
Arkhipova D.V., Privalova E.V., Kozlovskaya L.V., Kornev B.M., Popova E.N., Kraeva V.V., Osipenko V.I., Bitsadze V.O.
Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases
Kukes V.G., Ostroumova O.D., Mamaev V.I., Batutina A.M., Abakumov Y.E., Zykova A.A.
Pulse wave velocity and other indicators of arterial stiffness in hypertension comorbidity and chronic obstructive pulmonary disease
Aksenova T.A., Gorbunov V.V., Tsarenok S.Y.
Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study
Veselova T.N., Demchenkova A.Y., Martynyuk T.V., Danilov N.M., Ternovoy S.K., Chazova I.E.
Chronic obstructive pulmonary disease and comorbidities
Chuchalin A.G.
Tissue myocardial Doppler echocardiographic evaluation of right heart function and the level natriuretic peptides in patients with pulmonary hypertension of various etiologies
Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E., Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E.
Risk stratification methods and their significance in pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A.
The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation
Chazova I.E., Martynyuk T.V., Valieva Z.S., Nakonechnikov S.N., Nedogoda S.V., Salasyuk A.S., Taran I.N., Gratsianskaya S.E.
Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases
Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Novikova D.S., Markelova E.I., Volkov A.V.
Natriuretic peptides in diagnosis of pulmonary hypertension
Kuznetsova A.V., Fomin V.V., Popova I.A., Popova E.N., Kuznetsova A.V., Fomin V.V., Popova I.A., Popova E.N.
Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension
Butorov I.V., Verbitsky О.N., Butorov S.I.
Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases
Arkhipova D.V., Kornev B.M., Popova E.N., Kogan E.A., Osipenko V.I., Privalova E.V., Kobylensky A.G., Mescheryakova S.A., Efremov E.E.
Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat
Martynyuk T.V., Shmalts A.A., Gorbachevsky S.V., Chazova I.E.
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
Volkov A.V., Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Nasonov E.L.
HIV/AIDS masks in a therapist’s practice
Roshchina A.A., Ponomareva E.Y., Rebrov A.P.
First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
Avdeev S.N., Tsareva N.A., Nekliudova G.V., Chuchalin A.G.
Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
Martyniuk T.V., Konosova I.D., Chazova I.E.
Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension
Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoylenko L.E., Chazova I.E., Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoilenko L.E., Chazova I.E.
Prostaglandin E1. Mechanisms of action and clinical potentialities
Alferov A.V., Aizenberg L.V.
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)
Chazova I.E., Martynyuk T.V.
Progressive pulmonary hypertension in a patient with type 1 Gaucher disease
Ponomarev R.V., Model S.V., Averbukh O.M., Gavrilov A.M., Galstyan G.M., Lukina E.A.
Non-drug rehabilitation of patients with chronic obstructive pulmonary disease concurrent with hypertension
Sevostyanova E.V., Nikolaev Y.A., Bogdankevich N.V., Lusheva V.G., Markova E.N., Dolgova N.A.
Pulmonary hypertension in rheumatic heart disease: current approaches to diagnosis and therapy
Shostak N.A., Klimenko A.A., Novikov I.V., Demidova N.A., Aksenova A.V.
Vasoregulating activity of the endothelium and pulmonary hypertension
Karoli N.A., Rebrov A.P.
Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry
Valieva Z.S., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E.
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension
Moisseeva O.M., Rudakova A.V.
A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension
Arkhipova O.A., Martynyuk T.V., Chazova I.E.
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension
Avdeev S.N.
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
Avdeev S.N.
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension
Chazova I.E., Avdeev S.N., Tsareva N.A., Volkov A.V., Martyniuk T.V., Nakonechnikov S.N.
51 - 88 of 88 Items << < 1 2 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"